While Chemours Company has overperformed by 2.20%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CC fell by -45.98%, with highs and lows ranging from $29.21 to $13.09, whereas the simple moving average fell by -29.70% in the last 200 days.
On January 28, 2025, Truist started tracking Chemours Company (NYSE: CC) recommending Buy. A report published by UBS on July 09, 2024, Upgraded its rating to ‘Buy’ for CC. Mizuho also rated CC shares as ‘Neutral’, setting a target price of $25 on the company’s shares in an initiating report dated June 07, 2024. BMO Capital Markets April 09, 2024d the rating to Outperform on April 09, 2024, and set its price target from $19 to $34. UBS March 05, 2024d its ‘Buy’ rating to ‘Neutral’ for CC, as published in its report on March 05, 2024. BMO Capital Markets’s report from February 29, 2024 suggests a price prediction of $19 for CC shares, giving the stock a ‘Underperform’ rating. RBC Capital Mkts also rated the stock as ‘Outperform’.
Analysis of Chemours Company (CC)
It’s important to note that CC shareholders are currently getting $1.00 per share in dividends, so investors will receive a return regardless of how the company performs. Further, the quarter-over-quarter increase in sales is 2.42%, showing a positive trend in the upcoming months.
Chemours Company’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of 12.98% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.86, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and CC is registering an average volume of 2.00M. On a monthly basis, the volatility of the stock is set at 5.36%, whereas on a weekly basis, it is put at 5.42%, with a loss of -0.99% over the past seven days. Furthermore, long-term investors anticipate a median target price of $22.64, showing growth from the present price of $13.96, which can serve as yet another indication of whether CC is worth investing in or should be passed over.
How Do You Analyze Chemours Company Shares?
A giant in the Specialty Chemicals market, Chemours Company (CC) is based in the USA. When comparing Chemours Company shares with other companies under Basic Materials, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 24.11, there is a growth in quarterly earnings of 69.49%.
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.68%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 84.87% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CC shares are owned by institutional investors to the tune of 84.87% at present.
